Tilomisole
Tilomisole (Wy 18251) is a benzimidazothiazole experimental agent with anti-inflammatory activity. Tilomisole causes less agranulocytosis than levamisole, but retains immunomodulating capabilities. Tilomisole is orally active. Tilomisole has the potential for the research of cancer and inflammation[1][2].
Product Specifications
Product Name Alternative
Wy 18251
UNSPSC
12352005
Target
COX
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tilomisole.html
Solubility
10 mM in DMSO
Smiles
O=C(CC1=C(C2=CC=C(Cl)C=C2)N3C4=C(C=CC=C4)N=C3S1)O
Molecular Formula
C17H11ClN2O2S
Molecular Weight
342.80
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-106050/Tilomisole-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-106050/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[58433-11-7]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
